<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the frequency of <z:mp ids='MP_0004740'>sensorineural hearing loss</z:mp> (SNHL) in patients with <z:e sem="disease" ids="C0026272" disease_type="Disease or Syndrome" abbrv="MCTD">mixed connective tissue disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The study population consisted of 71 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> (69 female; 2 male), with a mean age of 57.1 +/- 7.9 years and a mean disease duration of 14.5 +/- 8.0 years </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent audiological evaluation that included pure tone and speech audiometry </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, the systemic manifestations of the disease and drug therapy were recorded </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were tested for presence of autoantibodies </plain></SENT>
<SENT sid="5" pm="."><plain>Fifty-one age-matched healthy subjects served as controls </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: SNHL was found in 33 (46.4%) of the 71 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>There was no correlation between SNHL and age and disease duration </plain></SENT>
<SENT sid="8" pm="."><plain>An association was found between <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud's phenomenon</z:e> (p &lt; 0.03), <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> (APS) (p &lt; 0.05), and SNHL </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> patients with SNHL had higher serum levels of anti-U1RNP (p &lt; 0.05), antiendothelial cell antibodies (p &lt; 0.001), and IgG type anticardiolipin antibodies (p &lt; 0.0001) than patients without SNHL </plain></SENT>
<SENT sid="10" pm="."><plain>Serum levels of interferon-gamma and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha were increased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> patients with SNHL compared to patients without SNHL </plain></SENT>
<SENT sid="11" pm="."><plain>The absolute number of natural (CD4+CD25(high)FoxP+) regulatory T cells (Treg) was lower compared to patients without SNHL </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e>, SNHL is a specific organ manifestation and appears frequently </plain></SENT>
<SENT sid="13" pm="."><plain>We have found that pathogenic autoantibodies, decreased levels of regulatory T cells, and overexpression of proinflammatory cytokines may play a role in the pathogenesis of immune mediated <z:e sem="disease" ids="C0494559" disease_type="Disease or Syndrome" abbrv="">inner ear disorders</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e> </plain></SENT>
</text></document>